FDA Approves Botox for Chronic Migraine Treatment - Drug approved for administration every 12 weeks in an effort to reduce future headache symptoms - ModernMedicine
Links shared publicly online about this topic.
- 766total visits
FDA Approves Botox for Chronic Migraine Treatment - Drug approved for administration every 12 weeks in an effort to reduce future headache symptoms - ModernMedicine
On Friday, Oct. 15, 2010, the U.S. Food and Drug Administration announced the approval of onabotulinumtoxinA (Botox) injection for the prevention of headaches in adult patients with chronic migraines.
View full resource at modernmedicine.com
Tags: Spasmodic Torticollis Medication, Migraine, Headache, Vascular Headache, Botox, Drug, FDA
Most Recently Shared on October 29, 2010 at 6:11 pm By:
FDA Approves Botox for Chronic Migraine Treatment - ModernMedicine: http://bit.ly/cAylZg via @addthis
Advertisement
